Aroa Biosurgery Ltd
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and co… Read more
Aroa Biosurgery Ltd (ARX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.045x
Based on the latest financial reports, Aroa Biosurgery Ltd (ARX) has a cash flow conversion efficiency ratio of 0.045x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$3.64 Million) by net assets (AU$80.93 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Aroa Biosurgery Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Aroa Biosurgery Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Aroa Biosurgery Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aroa Biosurgery Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fonar Corporation
NASDAQ:FONR
|
0.001x |
|
Paiho Shih Holdings Corp
TW:8404
|
0.025x |
|
Fiera Milano S.p.A.
LSE:0EGH
|
-0.673x |
|
Singatron Enterprise Co Ltd
TWO:6126
|
0.017x |
|
Lagenda Properties Bhd
KLSE:7179
|
-0.018x |
|
CAMBI ASA NK -02
F:3W7
|
N/A |
|
Korea Alcohol Industrial Co. Ltd
KQ:017890
|
0.025x |
|
Hung -Gu Oil Ltd
KQ:024060
|
0.020x |
Annual Cash Flow Conversion Efficiency for Aroa Biosurgery Ltd (2014–2025)
The table below shows the annual cash flow conversion efficiency of Aroa Biosurgery Ltd from 2014 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | AU$84.59 Million | AU$-2.33 Million | -0.028x | +64.51% |
| 2024-03-31 | AU$87.09 Million | AU$-6.76 Million | -0.078x | -109.81% |
| 2023-03-31 | AU$95.38 Million | AU$-3.53 Million | -0.037x | +67.71% |
| 2022-03-31 | AU$93.40 Million | AU$-10.71 Million | -0.115x | -22.95% |
| 2021-03-31 | AU$53.69 Million | AU$-5.01 Million | -0.093x | -471.64% |
| 2020-03-31 | AU$62.86 Million | AU$1.58 Million | 0.025x | +4523.65% |
| 2019-03-31 | AU$11.52 Million | AU$-6.54K | -0.001x | +99.96% |
| 2018-03-31 | AU$1.77 Million | AU$-2.80 Million | -1.586x | -1251.70% |
| 2017-03-31 | AU$6.28 Million | AU$-737.06K | -0.117x | -70.03% |
| 2016-03-31 | AU$5.91 Million | AU$-408.04K | -0.069x | +64.65% |
| 2015-03-31 | AU$6.92 Million | AU$-1.35 Million | -0.195x | -8.88% |
| 2014-03-31 | AU$7.58 Million | AU$-1.36 Million | -0.179x | -- |